Vβ TCR Repertoire Reported in CTCL and Autoimmune Diseases
Disease . | Author . | Methods . | Patients . | Site . | Vβ Dominant . |
---|---|---|---|---|---|
CTCL | Hunt et al60 | 7 MoAbs | 13 | Skin | Vβ 5 |
CTCL | Jack et al39 | 2 MoAbs | 16 | Skin/tumor | Vβ 8 |
CTCL | Lessin et al43 | RNA-PCR assay | 1 | PBL | Vβ 6.4 |
MF | Wood et al40 | RNA-PCR assay | 1 | Skin | Multiple with Vβ 6 dominant |
MF | Bahler et al41 | RNA-PCR assay | 28 | Skin | Multiple families with Vβ 6 & 8 dominant |
SS | Kono et al61 | RNA-PCR assay | 19 | PBL | Multiple with Vβ 8 |
CTCL | Longley et al44 | RNA-PCR assay + Abs | 6 | PBL | Polyclonal random |
SS | Gorochov et al42 | RNA-PCR assay | 16 | Skin | Vβ 5, 6, 8, 13, 18 |
RA | Paliard et al62 | RNA-PCR assay | 6 | Skin/PBL | Multiple with Vβ 14 dominant |
RA | Howell et al63 | RNA-PCR assay | 5 | Synovial fluid | Multiple with Vβ 14, 17 dominant |
RA | Bucht et al64 | RNA-PCR assay | 9 | Synovial fluid | Random |
Psoriasis | Chang et al52 | RNA-PCR assay | 8 | Skin/PBL | Multiple with Vβ 3, 13.1 dominant |
Kawasaki | Abe et al5 | RNA-PCR assay + Abs | 19 | PBL | Multiple with Vβ 2, 8 dominant |
Disease . | Author . | Methods . | Patients . | Site . | Vβ Dominant . |
---|---|---|---|---|---|
CTCL | Hunt et al60 | 7 MoAbs | 13 | Skin | Vβ 5 |
CTCL | Jack et al39 | 2 MoAbs | 16 | Skin/tumor | Vβ 8 |
CTCL | Lessin et al43 | RNA-PCR assay | 1 | PBL | Vβ 6.4 |
MF | Wood et al40 | RNA-PCR assay | 1 | Skin | Multiple with Vβ 6 dominant |
MF | Bahler et al41 | RNA-PCR assay | 28 | Skin | Multiple families with Vβ 6 & 8 dominant |
SS | Kono et al61 | RNA-PCR assay | 19 | PBL | Multiple with Vβ 8 |
CTCL | Longley et al44 | RNA-PCR assay + Abs | 6 | PBL | Polyclonal random |
SS | Gorochov et al42 | RNA-PCR assay | 16 | Skin | Vβ 5, 6, 8, 13, 18 |
RA | Paliard et al62 | RNA-PCR assay | 6 | Skin/PBL | Multiple with Vβ 14 dominant |
RA | Howell et al63 | RNA-PCR assay | 5 | Synovial fluid | Multiple with Vβ 14, 17 dominant |
RA | Bucht et al64 | RNA-PCR assay | 9 | Synovial fluid | Random |
Psoriasis | Chang et al52 | RNA-PCR assay | 8 | Skin/PBL | Multiple with Vβ 3, 13.1 dominant |
Kawasaki | Abe et al5 | RNA-PCR assay + Abs | 19 | PBL | Multiple with Vβ 2, 8 dominant |
Abbreviations: MoAbs, monoclonal antibodies; Abs, antibodies; PBL, peripheral blood lymphocytes.